Devon Energy Ventures manager Kyle Haustveit tells GCV the team recently closed a third fund investment, after the parent firm’s first two commitments to Altira Group Fund VI and VII. Devon Energy was the top performing stock on the S&P 500 in 2021.

Three carmakers helped semiconductor producer CanSemi raise $670m while 574 Invest, RATP Group and Groupe Chopard backed a $167m round for vehicle charging network Electra.

Chanel and Kraft Group were among the investors in Evolved By Nature’s $120m series C round, while Prosus led a $39m series B for Sharebite.

Siemens and Volkswagen provided $450m for the latter's Electrify America subsidiary while Leaps by Bayer helped push ReCode Therapeutics‘ series B round to $200m.

A range of corporates helped hydrogen system developer Electric Hydrogen raise $198m while Shell and Chevron backed fusion energy system developer Zap's $160m series C.

Illumina and Celgene could exit genome researcher Human Longevity in a reverse merger while Openly raised $75m from investors including Advance Venture Partners and Gradient Ventures.

GV took part in food delivery service Wonder Group’s $350m series B round while two Hanwha subsidiaries contributed to a $145m round for eVTOL aircraft developer Overair.

The Arm-backed accelerator picked six companies for its largest cohort yet, focusing on hardware, manufacturing and knowledge.

GV participated in tech apprenticeship platform Multiverse’s $220m series D round while Amgen, UCB, UPMC and Takeda helped genetics disease drug developer Code Biotherapeutics raise $75m.

The Russia-based steelmaker’s Severstal Ventures unit is shutting down amid geopolitical crisis-induced sanctions.